To further confirm that the mevalonate pathway contributes to tumor growth of ASPP2-depletion HCC cells in vivo, HCC-LM3 cells expressing shASPP2 or shNon were injected into the flank of nude mice, treated with or without simvastatin. Here, TP53BP2 is linked to neoplasm.